Sildenafil-induced relapse in bipolar disorder: Is nitric oxide the mechanism? [2]

International Journal of Neuropsychopharmacology

Volumn 7, Issue 4, 2004, Pages 525-

  Baggott, Jonathan ^a   Singh, Ashok N ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b LINCOLNSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPHASE; CYCLIC GMP; DOSULEPIN; FLUPENTIXOL DECANOATE; LITHIUM; METHYLENE BLUE; NITRIC OXIDE; SILDENAFIL; ZUCLOPENTHIXOL ACETATE;

ADULT; BIPOLAR DISORDER; CASE REPORT; HUMAN; IMPOTENCE; LETTER; MALE; PRIORITY JOURNAL; RELAPSE;

ADULT; BIPOLAR DISORDER; HUMANS; IMPOTENCE; MALE; METHYLENE BLUE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RECURRENCE;

EID: 10644239142     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146114570400464X     Document Type: Letter

References (5)

1. Bodini P (1899). The calming effects of Methylene blue on the insane [in French]. Semaine Médicale 7, 56.
2. Karatinos J, Rosse R, Deutsch S (1995). The nitric oxide pathway: potential for treatment of psychiatric disorders. Clinical Neuropharmacology 18, 482-499.
3. Langtry HD, Markham A (1999). Sildenafil. A review of its use in erectile dysfunction. Drugs 12, 967-968.
4. Marczin N, Ryan US, Catravas JD (1992). Methylene blue inhibits nitrovasodilator and endothelium derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. Journal of Pharmacology and Experimental Therapeutics 263, 170-179.
5. Narsapur S, Naylor G (1983). Methylene blue: a possible treatment for manic depressive psychosis. Journal of Affective Disorders 5, 155-161.